TipRanks
Go Ultimate55% OFF

Compare Tvardi Therapeutics (TVRD) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:TVRDTvardi TherapeuticsCHF 8.72M-0.28―Moderate BuyUnlock the CH:TVRD analyst price target with TipRanks PremiumCH:TVRDUnlock the CH:TVRD top-analyst price target with TipRanks Premium
CUECue Biopharma$20.40$151.61M-0.77-0.53%Moderate BuyUnlock the CUE analyst price target with TipRanks PremiumCH:TVRD vs CUEUnlock the CUE top-analyst price target with TipRanks Premium
ALGSAligos Therapeutics$4.68$29.97M-0.66-41.46%Strong BuyUnlock the ALGS analyst price target with TipRanks PremiumCH:TVRD vs ALGSUnlock the ALGS top-analyst price target with TipRanks Premium
GNTAGenenta Science SpA Sponsored ADR$0.73$29.81M-1.67-78.47%―Unlock the GNTA analyst price target with TipRanks PremiumCH:TVRD vs GNTAUnlock the GNTA top-analyst price target with TipRanks Premium
ANLAdlai Nortye Ltd. Sponsored ADR$9.32$615.00M-4.88587.54%Strong BuyUnlock the ANL analyst price target with TipRanks PremiumCH:TVRD vs ANLUnlock the ANL top-analyst price target with TipRanks Premium

Performance Comparison

-250%0%250%500%750%1000%1250%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:TVRDTvardi Therapeutics―――
CUECue Biopharma20.87-0.65-3.04%
ALGSAligos Therapeutics4.80-2.73-36.25%
GNTAGenenta Science SpA Sponsored ADR0.62-1.94-75.86%
ANLAdlai Nortye Ltd. Sponsored ADR9.558.16587.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts